NMRA vs WY · $283.5M cap vs P/E 43, rev $7.12B
Neumora Therapeutics, Inc. (NMRA) versus Weyerhaeuser Company (WY) — a side-by-side from cached financials, not a winner call.
Neumora Therapeutics, Inc. (NMRA) is a biotechnology company listed on NASDAQ.
Weyerhaeuser Company (WY) is a reit - specialty company listed on NYSE.
NMRA does not have a complete income-statement cache yet.
Latest reported WY revenue for 2024-12-31 was $7.12B. Net income was $396.0M. Revenue was down 7.2% from 2023-12-31 to 2024-12-31. WY currently screens at market cap $17.54B and trailing P/E 43.4.
NMRA currently screens at market cap $283.5M. WY currently screens at market cap $17.54B and trailing P/E 43.4.
Not investment advice. Open the NMRA and WY stock pages for the full models.
Not investment advice.